Matches in Wikidata for { <http://www.wikidata.org/entity/Q61602030> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q61602030 description "article" @default.
- Q61602030 description "artículu científicu" @default.
- Q61602030 description "im Juli 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61602030 description "wetenschappelijk artikel" @default.
- Q61602030 description "наукова стаття, опублікована в липні 2000" @default.
- Q61602030 name "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 name "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 type Item @default.
- Q61602030 label "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 label "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 prefLabel "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 prefLabel "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 P1433 Q61602030-DAD0AC0E-8562-4C9F-96B6-EDC77CF0FFF4 @default.
- Q61602030 P1476 Q61602030-2A8059A8-17AB-4431-8498-805C08E20AA6 @default.
- Q61602030 P2093 Q61602030-49C597D5-A634-4E36-86C6-75F7353565C3 @default.
- Q61602030 P2093 Q61602030-CC99708E-953A-4FEF-87FF-E4435BEFA471 @default.
- Q61602030 P2093 Q61602030-D8291268-B4CE-475E-BEA5-7BD7380D2D68 @default.
- Q61602030 P2093 Q61602030-D95A730E-5BB2-4FBD-9B3F-F024199C676D @default.
- Q61602030 P304 Q61602030-DD82BA24-F0E4-4655-85A3-4EC5E00BB773 @default.
- Q61602030 P31 Q61602030-2F1E257B-D9A3-4A15-A7D4-B3AFFE4D3A6F @default.
- Q61602030 P356 Q61602030-6F782CB6-7072-419C-9E89-76843612A6FE @default.
- Q61602030 P407 Q61602030-AACC7B63-4777-498F-9E7E-12BAF53F23D1 @default.
- Q61602030 P433 Q61602030-8702A9E9-9A11-430F-A1A2-10B3E5309DCD @default.
- Q61602030 P478 Q61602030-0E6BC039-A92B-47BA-9751-8DC053F64C2D @default.
- Q61602030 P50 Q61602030-EA0C4103-F912-4682-BB19-971FF7B0342B @default.
- Q61602030 P577 Q61602030-EDF47A3B-947F-4B9F-BEB8-19FE7D40535C @default.
- Q61602030 P698 Q61602030-0876701D-E866-4B4D-A5B5-7481FA96CDA6 @default.
- Q61602030 P356 00002030-200007070-00023 @default.
- Q61602030 P698 10930165 @default.
- Q61602030 P1433 Q4651863 @default.
- Q61602030 P1476 "Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection" @default.
- Q61602030 P2093 "E Vaccher" @default.
- Q61602030 P2093 "J Gabarre" @default.
- Q61602030 P2093 "M Fasan" @default.
- Q61602030 P2093 "U Tirelli" @default.
- Q61602030 P304 "1457-1458" @default.
- Q61602030 P31 Q13442814 @default.
- Q61602030 P356 "10.1097/00002030-200007070-00023" @default.
- Q61602030 P407 Q1860 @default.
- Q61602030 P433 "10" @default.
- Q61602030 P478 "14" @default.
- Q61602030 P50 Q53394076 @default.
- Q61602030 P577 "2000-07-01T00:00:00Z" @default.
- Q61602030 P698 "10930165" @default.